SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0000950123-00-007930
Filing Date
2000-08-22
Accepted
2000-08-22 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 NYMOX PHARMACEUTICAL CORPORATION e424b3.txt 424B3 2030
  Complete submission text file 0000950123-00-007930.txt   3605
Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT, QUEBEC CANADA, H4M 2V2 A8
Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT, QUEBEC CANADA H4M 2V2 A8 514-332-3222
NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-31310 | Film No.: 707520
SIC: 2835 In Vitro & In Vivo Diagnostic Substances